JASPER THERAPEUTICS INC (JSPR)

US4718712023 - Common Stock

21.71  -0.41 (-1.85%)

After market: 21.5 -0.21 (-0.97%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/A
-66.81%		N/A
187.19%		N/A
1,570.04%		N/A
197.89%		N/A
90.40%		N/A
55.83%
EBITDA
YoY % growth
N/AN/A-36.456M-50.221M
-37.76%		-67.753M
-34.91%		N/A
-26.73%		N/A
-12.53%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-4.71M-20.683M
-339.13%		-36.833M
-78.08%		-51.196M
-38.99%		-68.861M
-34.50%		N/A
-4.97%		N/A
-18.00%		N/A
-28.47%		N/A
-34.94%		N/A
13.14%		N/A
72.36%		N/A
428.96%		N/A
226.83%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A-10.30
55.00%		-6.20
39.81%		N/A
24.88%		N/A
1.78%		N/A
-7.18%		N/A
-56.75%		N/A
5.97%		N/A
63.94%		N/A
173.19%		N/A
538.50%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.26
15.95%		-1.26
-22.03%		-1.32
-36.23%		-1.35
-9.05%		-1.45
-14.77%		-0.89
29.40%		-0.93
29.76%		-0.95
29.85%		-0.98
32.32%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-20.83M
-17.52%		-21.708M
-44.03%		-22.637M
-41.55%		-23.679M
-19.05%		-24.73M
-18.72%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -1.24
22.50%		-1.09-0.15-13.47%
Q2 2024
Q2Q % growth		 -0.97
35.33%		-1.110.1412.67%
Q1 2024
Q2Q % growth		 -1.03
35.63%		-1.250.2217.57%
Q4 2023
Q2Q % growth		 -1.50
58.33%		-1.650.158.94%
Q3 2023
Q2Q % growth		 -1.60
50.00%		-1.58-0.02-1.04%
Q2 2023
Q2Q % growth		 -1.50
48.28%		-1.530.031.83%
Q1 2023
Q2Q % growth		 -1.60
-166.67%		-1.660.063.41%
Q4 2022
Q2Q % growth		 -3.60
54.43%		-3.670.071.96%
Q3 2022
Q2Q % growth		 -3.20
84.24%		-3.490.298.40%
Q2 2022
Q2Q % growth		 -2.90 -3.200.309.26%
Q1 2022
Q2Q % growth		 -0.60 -3.572.9783.19%
Q4 2021
Q2Q % growth		 -7.90 -3.50-4.40-125.48%
Q3 2021
Q2Q % growth		 -20.30 -2.82-17.48-620.43%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -3.62% -2.91% -10.8%
RevenueN/A N/A N/A N/A